Cornerstone Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $213K | Sell |
425
-406
| -49% | -$195K | 0.02% | 259 |
|
|
2026
Q1 | $408K | Sell |
831
-60
| -7% | -$32.6K | 0.04% | 176 |
|
|
2025
Q4 | $516K | Sell |
891
-71
| -7% | -$40.2K | 0.05% | 152 |
|
|
2025
Q3 | $467K | Buy |
962
+209
| +28% | +$97.3K | 0.05% | 155 |
|
|
2025
Q2 | $305K | Sell |
753
-140
| -16% | -$58.5K | 0.03% | 181 |
|
|
2025
Q1 | $363K | Buy |
893
+158
| +21% | +$85.6K | 0.04% | 167 |
|
|
2024
Q4 | $391K | Sell |
735
-27
| -4% | -$14.8K | 0.04% | 164 |
|
|
2024
Q3 | $471K | Buy |
762
+21
| +3% | +$12.4K | 0.06% | 139 |
|
|
2024
Q2 | $410K | Sell |
741
-63
| -8% | -$36.1K | 0.06% | 141 |
|
|
2024
Q1 | $467K | Buy |
804
+53
| +7% | +$29.7K | 0.07% | 144 |
|
|
2023
Q4 | $399K | Buy |
751
+43
| +6% | +$20.8K | 0.06% | 155 |
|
|
2023
Q3 | $358K | Buy |
708
+41
| +6% | +$21.8K | 0.06% | 153 |
|
|
2023
Q2 | $348K | Buy |
667
+21
| +3% | +$11.3K | 0.06% | 164 |
|
|
2023
Q1 | $372K | Sell |
646
-25
| -4% | -$14.1K | 0.07% | 151 |
|
|
2022
Q4 | $370K | Buy |
671
+3
| +0.4% | +$1.59K | 0.07% | 144 |
|
|
2022
Q3 | $339K | Hold |
668
| – | – | 0.08% | 142 |
|
|
2022
Q2 | $363K | Hold |
668
| – | – | 0.08% | 136 |
|
|
2022
Q1 | $395K | Sell |
668
-20
| -3% | -$11.5K | 0.06% | 172 |
|
|
2021
Q4 | $459K | Buy |
688
+23
| +3% | +$14.4K | 0.07% | 181 |
|
|
2021
Q3 | $380K | Hold |
665
| – | – | 0.06% | 180 |
|
|
2021
Q2 | $335K | Sell |
665
-204
| -23% | -$96.3K | 0.06% | 177 |
|
|
2021
Q1 | $397K | Sell |
869
-61
| -7% | -$29.1K | 0.08% | 165 |
|
|
2020
Q4 | $433K | Hold |
930
| – | – | 0.09% | 153 |
|
|
2020
Q3 | $411K | Hold |
930
| – | – | 0.1% | 140 |
|
|
2020
Q2 | $337K | Hold |
930
| – | – | 0.09% | 134 |
|
|
2020
Q1 | $264K | Sell |
930
-7
| -0.7% | -$2.21K | 0.08% | 133 |
|
|
2019
Q4 | $304K | Hold |
937
| – | – | 0.06% | 141 |
|
|
2019
Q3 | $273K | Sell |
937
-19
| -2% | -$5.44K | 0.06% | 137 |
|
|
2019
Q2 | $281K | Sell |
956
-307
| -24% | -$84.6K | 0.06% | 136 |
|
|
2019
Q1 | $346K | Buy |
+1,263
| New | +$314K | 0.08% | 125 |
|
|
2018
Q4 | – | Sell |
-1,263
| Closed | -$308K | – | 154 |
|
|
2018
Q3 | $308K | Hold |
1,263
| – | – | 0.09% | 125 |
|
|
2018
Q2 | $262K | Hold |
1,263
| – | – | 0.09% | 125 |
|
|
2018
Q1 | $261K | Hold |
1,263
| – | – | 0.09% | 122 |
|
|
2017
Q4 | $240K | Hold |
1,263
| – | – | 0.08% | 133 |
|
|
2017
Q3 | $239K | Sell |
1,263
-53
| -4% | -$9.6K | 0.08% | 132 |
|
|
2017
Q2 | $230K | Hold |
1,316
| – | – | 0.08% | 130 |
|
|
2017
Q1 | $202K | Sell |
1,316
-931
| -41% | -$142K | 0.1% | 115 |
|
|
2016
Q4 | $317K | Buy |
2,247
+931
| +71% | +$137K | 0.24% | 64 |
|
|
2016
Q3 | $209K | Buy |
+1,316
| New | +$203K | 0.17% | 81 |
|
Other funds holding TMO
RG
ECSS
LT
ATO
Cornerstone Advisory's TMO Position: Q2 2026 in Review
Cornerstone Advisory reduced its Thermo Fisher Scientific (TMO) stake by 49% in Q2 2026, selling an estimated $195K and leaving 425 shares worth $213K. The position accounts for 0.02% of the portfolio, ranked #259.
Cornerstone Advisory first reported a position in TMO in Q3 2016 and has held it in 39 quarters since. The position peaked at $516K in Q4 2025. 1,030 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Cornerstone Advisory held 425 shares of Thermo Fisher Scientific worth $213K as of Q2 2026.
- Cornerstone Advisory sold 406 Thermo Fisher Scientific shares in Q2 2026, an estimated $195K.
- Thermo Fisher Scientific made up 0.02% of Cornerstone Advisory's portfolio in Q2 2026, its #259 holding.
- Cornerstone Advisory first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 39 quarters since.
- Cornerstone Advisory's Thermo Fisher Scientific position peaked at $516K in Q4 2025.
- 1,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Cornerstone Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.